DPT, OCS, Rehabilitation Services and Department of Radiological Sciences, Mail Stop 113, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis,TN 38105-3678 (USA).
Department of Radiological Sciences, St Jude Children's Research Hospital.
Phys Ther. 2020 Mar 10;100(3):509-522. doi: 10.1093/ptj/pzz176.
Glucocorticoids used to treat childhood leukemia and lymphoma can result in osteonecrosis, leading to physical dysfunction and pain. Improving survival rates warrants research into long-term outcomes among this population.
The objective of this study was to compare the physical function and quality of life (QOL) of survivors of childhood cancer who had an osteonecrosis history with that of survivors who had no osteonecrosis history and with that of people who were healthy (controls).
This was a cross-sectional study.
This study included St Jude Lifetime Cohort Study participants who were ≥ 10 years from the diagnosis of childhood leukemia or lymphoma and ≥ 18 years old; 135 had osteonecrosis (52.5% men; mean age = 27.7 [SD = 6.08] years) and 1560 had no osteonecrosis history (52.4% men; mean age = 33.3 [SD = 8.54] years). This study also included 272 people who were from the community and who were healthy (community controls) (47.7% men; mean age = 35.1 [SD = 10.46] years). The participants completed functional assessments and questionnaires about QOL.
Survivors with osteonecrosis scored lower than other survivors and controls for dorsiflexion strength (mean score = 16.50 [SD = 7.91] vs 24.17 [SD = 8.61] N·m/kg) and scored lower than controls for flexibility with the sit-and-reach test (20.61 [SD = 9.70] vs 23.96 [SD = 10.73] cm), function on the Physical Performance Test (mean score = 22.73 [SD = 2.05] vs 23.58 [SD = 0.88]), and mobility on the Timed "Up & Go" Test (5.66 [SD = 2.25] vs 5.12 [SD = 1.28] seconds). Survivors with hip osteonecrosis requiring surgery scored lower than survivors without osteonecrosis for dorsiflexion strength (13.75 [SD = 8.82] vs 18.48 [SD = 9.04] N·m/kg), flexibility (15.79 [SD = 8.93] vs 20.37 [SD = 10.14] cm), and endurance on the 6-minute walk test (523.50 [SD = 103.00] vs 572.10 [SD = 102.40] m).
Because some eligible survivors declined to participate, possible selection bias was a limitation of this study.
Survivors of childhood leukemia and lymphoma with and without osteonecrosis demonstrated impaired physical performance and reported reduced QOL compared with controls, with those requiring surgery for osteonecrosis most at risk for impairments. It may be beneficial to provide strengthening, flexibility, and endurance interventions for patients who have pediatric cancer and osteonecrosis for long-term function.
用于治疗儿童白血病和淋巴瘤的糖皮质激素可导致骨坏死,导致身体功能障碍和疼痛。提高生存率需要研究该人群的长期结果。
本研究旨在比较有骨坏死史的儿童癌症幸存者与无骨坏死史的幸存者以及健康对照者(对照组)的身体功能和生活质量(QOL)。
这是一项横断面研究。
本研究纳入了≥ 10 岁诊断为儿童白血病或淋巴瘤且≥ 18 岁的圣裘德终身队列研究参与者;135 例有骨坏死(52.5%为男性;平均年龄= 27.7 [SD= 6.08] 岁),1560 例无骨坏死史(52.4%为男性;平均年龄= 33.3 [SD= 8.54] 岁)。本研究还纳入了 272 名来自社区且健康的人(社区对照组)(47.7%为男性;平均年龄= 35.1 [SD= 10.46] 岁)。参与者完成了功能评估和关于 QOL 的问卷调查。
有骨坏死的幸存者在背屈力量方面的得分低于其他幸存者和对照组(平均得分= 16.50 [SD= 7.91] vs 24.17 [SD= 8.61] N·m/kg),在坐立伸展测试中的柔韧性方面的得分低于对照组(20.61 [SD= 9.70] vs 23.96 [SD= 10.73] cm),在身体表现测试中的功能方面的得分低于对照组(平均得分= 22.73 [SD= 2.05] vs 23.58 [SD= 0.88]),在计时“起身和行走”测试中的移动能力方面的得分低于对照组(5.66 [SD= 2.25] vs 5.12 [SD= 1.28] 秒)。需要手术治疗的髋关节骨坏死幸存者在背屈力量方面的得分低于无骨坏死幸存者(13.75 [SD= 8.82] vs 18.48 [SD= 9.04] N·m/kg),在柔韧性方面的得分低于无骨坏死幸存者(15.79 [SD= 8.93] vs 20.37 [SD= 10.14] cm),在 6 分钟步行测试中的耐力方面的得分低于无骨坏死幸存者(523.50 [SD= 103.00] vs 572.10 [SD= 102.40] m)。
由于一些符合条件的幸存者拒绝参与,因此本研究存在可能的选择偏倚。
有和无骨坏死的儿童白血病和淋巴瘤幸存者的身体表现受损,生活质量下降,与对照组相比,需要手术治疗骨坏死的患者风险最大。为患有儿科癌症和骨坏死的患者提供强化、柔韧性和耐力干预措施可能对长期功能有益。